BIOMARKER LEVELS FOLLOWING INTRAVENOUS BELIMUMAB IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS SUPPORT BENEFICIAL EFFECTS ON DISEASE ACTIVITY: RESULTS FROM THE PLUTO STUDY

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY(2020)

Cited 0|Views20
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined